- New findings from Patient/Donor project New findings from Anthony Nolan’s flagship Patient/Donor project have shown that sometimes a perfect match isn’t always…
- New research from leading charity Anthony Nolan could pave the way for a change in how stem cell donors are selected and save the lives of more people with blood cancer and blood…
- Today, in a world first, blood cancer charity Anthony Nolan has launched new technology which will improve stem cell transplant outcomes and make the best patient-donor matches…
- A research breakthrough by scientists at the blood cancer charity Anthony Nolan could lead to better outcomes for patients having stem cell transplants using umbilical cord blood…
- Jonathan in the Patient Services team discusses recent research into the use of cell therapies to treat Graft versus Host Disease (GvHD), which is a common side effect of stem…
- Daniel Gibson, Head of Innovation and Commercialisation talks about the advancements in cellular therapy research, and how we are overcoming critical issues in the supply of…
- After new findings from Anthony Nolan’s Patient/Donor project have been published, Jonathan from our Patient Services team looks at how new technology is helping us understand…
- In celebration of British Science Week 2021 Dr Jonathan Kay, Anthony Nolan’s Science Communications Manager, looks at the possibility of using a type of cell found in cord blood…
- Is cryopreserved cellular material really a reliable source of starting material? Catch up with Chris Leonforte, Head of Cell & Gene Therapy Manufacturing at Anthony Nolan to…
- To further improve the experience of patients and staff at transplant centres when selecting and requesting cord blood units for UK patients, the Anthony Nolan/NHSBT Cord Support…
This page has been auto translated by Google Translate. Confirm any health information with your own medical team before acting upon it. All printed materials and PDFs are available in English only.